Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. U. Yood
Abstract C-A2-05: Pneumonia Risk Among COPD Patients Using Fluticasone/Salmeterol Versus Other Inhaled Steroids and Bronchodilators Alone
Clinical Medicine and Research
Medicine
Home Care
Community
Related publications
Pneumonia Risk in COPD Patients Receiving Inhaled Corticosteroids Alone or in Combination: TORCH Study Results
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Cost-Effectiveness of Combination Fluticasone Propionate–salmeterol 250/50 Μg Versus Salmeterol in Severe COPD Patients
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Improvement in Asthma Endpoints When Aiming for Total Control: Salmeterol/Fluticasone Propionate Versus Fluticasone Propionate Alone
Primary Care Respiratory Journal
The Relationship Among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia
Annals of the American Thoracic Society
Pulmonary
Respiratory Medicine
Survival in COPD Patients After Regular Use of Fluticasone Propionate and Salmeterol in General Practice
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Fluticasone Alone or in Combination With Salmeterol vs Triamcinolone in Asthma
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Regular Treatment With Salmeterol and Inhaled Steroids for Chronic Asthma: Serious Adverse Events
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids
Journal of the American Medical Directors Association
Medicine
Health Policy
Gerontology
Geriatrics
Nursing
Cost-Effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science